SMARCB1(INI1)-deficient undifferentiated carcinoma with rhabdoid features of anorectal origin

Keyphrases

• Rhabdoid Features 100%
• SMARCB1 100%
• INI1 100%
• Undifferentiated Carcinoma 100%
• Chemoradiation Therapy 40%
• Carcinoma 40%
• Canal 40%
• 5-fluorouracil (5-FU) 40%
• Tumor 20%
• Tumor Cells 20%
• Primary Tumor 20%
• Protein Expression 20%
• Potential Gains 20%
• Squamous Carcinoma 20%
• Gastrointestinal Tract 20%
• Poor Prognosis 20%
• Palliation 20%
• Radiation Therapy 20%
• Lymph Node Involvement 20%
• Therapeutic Response 20%
• Cisplatin-based Chemotherapy 20%
• Gastrointestinal 20%
• Radiologic 20%
• Tumor Regression 20%
• Pregnant Women 20%
• Concurrent Radiation 20%
• Pelvic Lymph Nodes 20%
• Locoregional Control 20%
• Soft Tissue Tumor 20%
• Rhabdoid 20%
• Immunophenotyping 20%
• Therapeutic Guidance 20%
• Platinum-based 20%
• Inguinal Lymph Node 20%
• INI-1 Deficient 20%

Medicine and Dentistry

• Carcinoma 100%
• Anaplastic Carcinoma 100%
• Chemoradiation Therapy 66%
• Treatment Response 33%
• Tumor Cell 33%
• Primary Tumor 33%
• Gastrointestinal Tract 33%
• Pelvis 33%
• Protein Expression 33%
• Symptomatic Treatment 33%
• Tumor 33%
• Cisplatin 33%
• Fluorouracil 33%
• Tumor Regression 33%
• Soft Tissue Tumor 33%
• Biopsy Technique 33%
• Immunophenotyping 33%
• Inguinal Lymph Node 33%
• Diseases 33%
• Radiation Therapy 33%